- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06590441
Investigation of Wearing Compliance of Spectacles for Myopia Control
November 13, 2025 updated by: CooperVision, Inc.
A Multisite Investigation of the Wearing Compliance of Spectacles for Myopia Control
The goal of this observational study was to compare the wearing patterns of spectacles prescribed for myopia control in juvenile wearers.
Study Overview
Detailed Description
This unmasked, multi-center, observational study evaluated the wearing patterns of established (use of ≥3 months) juvenile spectacles wearers.
It aimed to compare the wearing patterns of spectacles for myopia control between males and females.
Wearing pattern were measured via the use of temperature sensors fitted to the sides of the participant's spectacles.
Data from the final week of the 1-month study was used for analysis to minimize 'unusual' wear patterns which may have occurred early in the study.
Study Type
Observational
Enrollment (Actual)
53
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cheshire
-
Sale, Cheshire, United Kingdom, M33 7XF
- Eye2C Ltd
-
-
England
-
Darwen, England, United Kingdom, BB3 2AA
- Susan Hilton Ltd
-
-
Leeds
-
Oakwood, Leeds, United Kingdom, LS8 2HU
- Columbo Ltd
-
-
Rossendale
-
Haslingden, Rossendale, United Kingdom, BB4 5QN
- David Gould Opticians Limited
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Juvenile participants recruited directly from the patient bases of several UK optometry practices who currently wear spectacles prescribed for myopia
Description
Inclusion Criteria:
- They are aged between six and 15 years old.
- Their parent or guardian understands the rights of the subject and are willing to sign a statement of informed consent.
- They understand the study at a level appropriate for their age and are willing to sign a statement of assent.
- They and their parents or guardians are willing and able to follow the protocol.
- They currently use spectacle lenses for myopia control and have done so for at least three months.
- They agree not to participate in other clinical research for the duration of this study.
Exclusion Criteria:
- They have an unusual ophthalmic history, which in the opinion of the site investigator or Principal Investigator might impact on the successful conduct of the study.
- They are amblyopic.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Myopia control spectacle wearers
Established (use of ≥3 months) juvenile myopia control spectacle wearers
|
Myopia control spectacles fitted with temperature sensors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Wearing Pattern of Myopia Control Spectacles
Time Frame: Measured continuously over 1 week of wear
|
Overall wearing patterns were evaluated via the use of temperature sensors fitted to the frame of the spectacles.
The temperature readings from the final week of the one month study were used to determine when spectacles were worn or removed.
Scores were calculated as the average times over a 24 hour period (W24) where a higher score indicated that the spectacles were worn for a longer period of time per day.
|
Measured continuously over 1 week of wear
|
|
Effect of Sex on Overall Wearing Pattern
Time Frame: Measured continuously over 1 week of wear
|
The effect of sex on the overall wearing pattern was evaluated via the use of temperature sensors fitted to the frame of the spectacles.
The temperature readings from the final week of the one month study were used to determine when spectacles were worn or removed.
Scores were calculated as the average times over a 24 hour period (W24) and a 'waking day' period of 07:00 to 21:00 (W14), where a higher score indicated that the spectacles were worn for a longer period of time per day.
|
Measured continuously over 1 week of wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip Morgan, Eurolens Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2024
Primary Completion (Actual)
January 18, 2025
Study Completion (Actual)
January 18, 2025
Study Registration Dates
First Submitted
August 30, 2024
First Submitted That Met QC Criteria
September 4, 2024
First Posted (Actual)
September 19, 2024
Study Record Updates
Last Update Posted (Actual)
November 25, 2025
Last Update Submitted That Met QC Criteria
November 13, 2025
Last Verified
October 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-160
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on Myopia control spectacles
-
Dopavision GmbHCompletedMyopiaSpain, Netherlands, Germany, Portugal, United Kingdom
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Beijing Airdoc Technology Co., Ltd.Eye & ENT Hospital of Fudan UniversityRecruiting
-
Essilor InternationalActive, not recruiting
-
Indizen Optical Technologies, S.L.U.University of Minho; University of Ulster; Hospital San Carlos, MadridNot yet recruitingMyopia ProgressionSpain, Portugal, United Kingdom
-
Ohio State UniversityAmerican Academy of Optometry; Transitions; Ohio Lions Eye Research Foundation; College of Optometrists in Vision Development and other collaboratorsCompleted
-
Indizen Optical Technologies, S.L.U.Universidad Europea de MadridCompleted
-
CooperVision, Inc.CompletedAmetropiaUnited Kingdom
-
University Hospital AugsburgEnrolling by invitation